Long-term complications in youth-onset type 2 diabetes

Keyphrases

• Dyslipidemia 100%
• Long-term Complications 100%
• Metformin 100%
• Early-onset Type 2 Diabetes 100%
• Hyperglycemia 50%
• Hypertension 50%
• Diabetes 50%
• Diabetic Kidney Disease 50%
• Retinal Diseases 50%
• Minority Race 50%
• Ethnic Groups 50%
• Race Groups 50%
• Ethnic Minorities 50%
• Nerve Disease 50%
• Risk Factors 25%
• Adverse Events 25%
• Insulin 25%
• Complication Risk 25%
• Associated Complications 25%
• Advanced Stage 25%
• Cumulative Incidence 25%
• Diabetes Diagnosis 25%
• Young Adulthood 25%
• Vascular Complications 25%
• Glycemic Control 25%
• Kidney Disease 25%
• Digestive Diseases 25%
• Multicenter Clinical Trial 25%
• Rosiglitazone 25%
• Hypertension Disease 25%
• Intensive Lifestyle Intervention 25%
• Trial Participants 25%
• Hypertension Incidence 25%
• Youth Transitions 25%
• Transition to Adulthood 25%

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Dyslipidemia 100%
• Diabetes 75%
• Glycon 75%
• Prevalence 50%
• Hyperglycemia 50%
• Neuropathy 50%
• Ethnic Group 50%
• Retina Disease 50%
• Diabetic Nephropathy 50%
• Clinical Trial 25%
• Adverse Event 25%
• Cumulative Incidence 25%
• Lifestyle Intervention 25%
• Glycemic Control 25%
• Metformin Plus Rosiglitazone 25%
• Microvascular Complication 25%
• Kidney Disorder 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Dyslipidemia 100%
• Maturity Onset Diabetes of the Young 100%
• Metformin 75%
• Hyperglycemia 50%
• Prevalence 50%
• Neuropathy 50%
• Retina Disease 50%
• Diabetic Nephropathy 50%
• Clinical Trial 25%
• Adverse Event 25%
• Kidney Disease 25%
• Gastrointestinal Disease 25%
• Metformin Plus Rosiglitazone 25%